Remarkable response to ceritinib and brigatinib in an anaplastic lymphoma kinase-rearranged anaplastic thyroid carcinoma previously treated with crizotinib

Nom du journal : Thyroid

Année : 2019

Volume : doi: 10.1089/thy.2019.0202 [Epub ahead of print]

Auteurs: Leroy L, Bonhomme B, Godbert Y, Le Moulec S, Italiano A, Soubeyran I,